Akero Therapeutics (AKRO) PT Raised to $45 at H.C. Wainwright After Ph2a Results
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $45.00 (from $33.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
